Annual EBITDA
-$86.02 M
+$6.30 M+6.82%
December 31, 2023
Summary
- As of February 7, 2025, BDTX annual EBITDA is -$86.02 million, with the most recent change of +$6.30 million (+6.82%) on December 31, 2023.
- During the last 3 years, BDTX annual EBITDA has fallen by -$18.82 million (-28.01%).
- BDTX annual EBITDA is now -1806.12% below its all-time high of -$4.51 million, reached on December 31, 2017.
Performance
BDTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$18.04 M
+$4.00 M+18.15%
September 30, 2024
Summary
- As of February 7, 2025, BDTX quarterly EBITDA is -$18.04 million, with the most recent change of +$4.00 million (+18.15%) on September 30, 2024.
- Over the past year, BDTX quarterly EBITDA has increased by +$5.85 million (+24.49%).
- BDTX quarterly EBITDA is now -496.10% below its all-time high of -$3.03 million, reached on December 31, 2018.
Performance
BDTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$81.02 M
+$5.85 M+6.74%
September 30, 2024
Summary
- As of February 7, 2025, BDTX TTM EBITDA is -$81.02 million, with the most recent change of +$5.85 million (+6.74%) on September 30, 2024.
- Over the past year, BDTX TTM EBITDA has increased by +$5.96 million (+6.86%).
- BDTX TTM EBITDA is now -2576.48% below its all-time high of -$3.03 million, reached on December 31, 2018.
Performance
BDTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BDTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.8% | +24.5% | +6.9% |
| 3 y3 years | -28.0% | +48.9% | +34.3% |
| 5 y5 years | -870.9% | -95.0% | -130.0% |
BDTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +32.1% | at high | +30.5% | at high | +36.0% |
| 5 y | 5-year | -144.3% | +32.1% | -82.9% | +48.9% | -130.0% | +36.0% |
| alltime | all time | -1806.1% | +32.1% | -496.1% | +48.9% | -2576.5% | +36.0% |
Black Diamond Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$18.04 M(-18.1%) | -$81.02 M(-6.7%) |
| Jun 2024 | - | -$22.04 M(+9.3%) | -$86.87 M(+2.5%) |
| Mar 2024 | - | -$20.16 M(-2.9%) | -$84.74 M(-1.5%) |
| Dec 2023 | -$86.02 M(-6.8%) | -$20.77 M(-13.1%) | -$86.02 M(-1.1%) |
| Sep 2023 | - | -$23.90 M(+20.0%) | -$86.98 M(+2.2%) |
| Jun 2023 | - | -$19.92 M(-7.1%) | -$85.08 M(-3.5%) |
| Mar 2023 | - | -$21.44 M(-1.3%) | -$88.20 M(-4.5%) |
| Dec 2022 | -$92.32 M(-27.1%) | -$21.73 M(-1.2%) | -$92.32 M(-4.4%) |
| Sep 2022 | - | -$22.00 M(-4.6%) | -$96.55 M(-12.1%) |
| Jun 2022 | - | -$23.05 M(-9.8%) | -$109.88 M(-9.6%) |
| Mar 2022 | - | -$25.55 M(-1.6%) | -$121.53 M(-4.1%) |
| Dec 2021 | -$126.67 M | -$25.96 M(-26.5%) | -$126.67 M(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$35.32 M(+1.8%) | -$123.32 M(+16.5%) |
| Jun 2021 | - | -$34.70 M(+13.0%) | -$105.90 M(+23.5%) |
| Mar 2021 | - | -$30.69 M(+35.7%) | -$85.76 M(+26.2%) |
| Dec 2020 | -$67.20 M(+90.9%) | -$22.61 M(+26.3%) | -$67.94 M(+23.1%) |
| Sep 2020 | - | -$17.90 M(+23.0%) | -$55.19 M(+18.6%) |
| Jun 2020 | - | -$14.56 M(+13.1%) | -$46.55 M(+5.2%) |
| Mar 2020 | - | -$12.87 M(+30.4%) | -$44.26 M(+25.7%) |
| Dec 2019 | -$35.21 M(+297.4%) | -$9.87 M(+6.6%) | -$35.22 M(+24.1%) |
| Sep 2019 | - | -$9.26 M(-24.6%) | -$28.39 M(+48.4%) |
| Jun 2019 | - | -$12.27 M(+220.6%) | -$19.13 M(+179.0%) |
| Mar 2019 | - | -$3.83 M(+26.5%) | -$6.86 M(+126.5%) |
| Dec 2018 | -$8.86 M(+96.3%) | -$3.03 M | -$3.03 M |
| Dec 2017 | -$4.51 M | - | - |
FAQ
- What is Black Diamond Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual EBITDA year-on-year change?
- What is Black Diamond Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly EBITDA year-on-year change?
- What is Black Diamond Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics TTM EBITDA year-on-year change?
What is Black Diamond Therapeutics annual EBITDA?
The current annual EBITDA of BDTX is -$86.02 M
What is the all time high annual EBITDA for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual EBITDA is -$4.51 M
What is Black Diamond Therapeutics annual EBITDA year-on-year change?
Over the past year, BDTX annual EBITDA has changed by +$6.30 M (+6.82%)
What is Black Diamond Therapeutics quarterly EBITDA?
The current quarterly EBITDA of BDTX is -$18.04 M
What is the all time high quarterly EBITDA for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly EBITDA is -$3.03 M
What is Black Diamond Therapeutics quarterly EBITDA year-on-year change?
Over the past year, BDTX quarterly EBITDA has changed by +$5.85 M (+24.49%)
What is Black Diamond Therapeutics TTM EBITDA?
The current TTM EBITDA of BDTX is -$81.02 M
What is the all time high TTM EBITDA for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high TTM EBITDA is -$3.03 M
What is Black Diamond Therapeutics TTM EBITDA year-on-year change?
Over the past year, BDTX TTM EBITDA has changed by +$5.96 M (+6.86%)